Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasmsSusann Winter, Shahram Kordasti, Sara Bencini et al.|Leukemia|2024Cited by 7
Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall SurvivalUta Oelschlaegel, Shahram Kordasti, Aida Santaolalla et al.|Blood|2021Cited by 1
Application of AI-Based Analytical Approaches for Multiplex Immunophenotyping of <i>SF3B1</i>-Mutant Myelodysplastic Syndrome SubtypeSusann Winter, Shahram Kordasti, Jessica A. Timms et al.|Blood|2021Cited by 0